Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial Kwaku Poku Asante , Salim Abdulla , Sélidji Todagbé Agnandji +39 more 2011 The Lancet Infectious Diseases 134 citations